Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.

Saved in:
Bibliographic Details
Title: Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.
Authors: Grkovski M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org., Krebs SS; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nuclear Medicine, Division of Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas., O'Donoghue JA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Kuten J; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Mauguen A; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; and., Shobeiri P; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Lafontaine D; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Thor M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Augensen F; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Fox JJ; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Pandit-Taskar N; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Nuclear Medicine Division, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Dunphy MP; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Bodei L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Schöder H; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Oct 01; Vol. 66 (10), pp. 1622-1630. Date of Electronic Publication: 2025 Oct 01.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.125.270170